Clinical Trial

Mass Balance Clinical Trial of SIM0270

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 27, 2024 (before its estimated March 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a single-center, non-randomized, open-label, single-cohort, single-dose phase I clinical study in healthy Chinese adult male subjects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-22.
Status change: Recruiting → Active, Not Recruiting 2024-11-26
Trial Details
NCT Number NCT06654791
Lead Sponsor Jiangsu Simcere Pharmaceutical Co., Ltd.
Collaborators: Nanjing Zaiming Pharmaceutical Co., Ltd.
Conditions Healthy Participants
Enrollment 6 participants
Start Date 2024-10-17
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-27